Last update 01 Nov 2024

Shanghai Saiyuan Biotechnology Co., Ltd.

Private Company|
2016|
Shanghai Shi, China

Overview

Tags

Digestive System Disorders
Neoplasms
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Top 5 Drug TypeCount
Monoclonal antibody1
Top 5 TargetCount
EGFR(Epidermal growth factor receptor erbB1)1

Related

1
Drugs associated with Shanghai Saiyuan Biotechnology Co., Ltd.
Ametumumab
Target
EGFR
Mechanism
EGFR antagonists
Active Org.
Shanghai Serum Bio-Technology Co., Ltd.Shanghai Serum Bio-Technology Co., Ltd. [+2]
Originator Org.
Academy of Military Medical SciencesAcademy of Military Medical Sciences
Active Indication
RAS Wild Type Colorectal Cancer
Inactive Indication
Advanced Malignant Solid Neoplasm
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Shanghai Saiyuan Biotechnology Co., Ltd.
CTR20222853 / Not yet recruitingPhase 2
安美木单抗联合抗 PD-1 单抗及 FOLFIRI 对比安美木或西妥昔单抗联合 FOLFIRI 治疗 RAS 野生型晚期结直肠癌患者的有效性和安全性的 IIb 期临床试验
[Translation] Phase IIb clinical trial of the efficacy and safety of amitumomab combined with anti-PD-1 mAb and FOLFIRI compared with amitumomab or cetuximab combined with FOLFIRI in patients with RAS wild-type advanced colorectal cancer
100 Clinical Results associated with Shanghai Saiyuan Biotechnology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Shanghai Saiyuan Biotechnology Co., Ltd.
Login to view more data
100 Deals associated with Shanghai Saiyuan Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Saiyuan Biotechnology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Ametumumab
 ( EGFR )		RAS Wild Type Colorectal Cancer
More
Phase 2
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free